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Abstract 1	
 2	
The Mycobacterium tuberculosis complex (MTBC) is the collective term given to the 3	
group of bacteria that cause tuberculosis (TB) in mammals. It has been reported that 4	
M. tuberculosis H37Rv, a standard reference MTBC strain, is attenuated in cattle compared to 5	
Mycobacterium bovis. However, as M. tuberculosis H37Rv was isolated in the early 1930s, 6	
and genetic variants are known to exist, we sought to revisit this question of attenuation of 7	
M. tuberculosis for cattle by performing a bovine experimental infection with a recent 8	
M. tuberculosis isolate. Here we report infection of cattle using M. bovis AF2122/97, 9	
M. tuberculosis H37Rv, and M. tuberculosis BTB1558, the latter isolated in 2008 during a TB 10	
surveillance project in Ethiopian cattle. We show that both M. tuberculosis strains caused 11	
reduced gross and histopathology in cattle compared to M. bovis. Using M. tuberculosis 12	
H37Rv and M. bovis AF2122/97 as the extremes in terms of infection outcome, we used 13	
RNA-Seq analysis to explore differences in the peripheral response to infection as a route to 14	
identify biomarkers of progressive disease in contrast to a more quiescent, latent infection. 15	
Our work shows the attenuation of M. tuberculosis strains for cattle, and emphasizes the 16	
potential of the bovine model as a ‘One Health’ approach to inform human TB biomarker 17	
development and post-exposure vaccine development.    18	
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Introduction 19	
 20	
The Mycobacterium tuberculosis complex (MTBC), the group of pathogens that 21	
cause tuberculosis (TB) in mammals, show distinct host preference. Mycobacterium 22	
tuberculosis is the hallmark member of the MTBC and the most deadly human pathogen 23	
globally, with close to 2 billion people infected worldwide 1. The animal-adapted members of 24	
the MTBC are named after the host of initial/most frequent isolation, and comprise: the 25	
exemplar animal pathogen and predominant agent of bovine TB M. bovis 2; M. microti 3; the 26	
‘Dassie bacillus’ 4,5; M. caprae 6; M. pinnipedii 7; M. orygis 8, and M. mungi 9. A caveat is that 27	
these species designations do not define host exclusivity; MTBC members can infect a range 28	
of mammals to greater or lesser degrees. The central feature of host adaptation is the ability to 29	
sustain within a host population. Thus, M. bovis can infect and cause disease in humans; 30	
however, the capacity of M. bovis to transmit between immunologically competent humans is 31	
severely limited compared to M. tuberculosis 10,11. Similarly, reports suggest that 32	
M. tuberculosis appears attenuated in a bovine host compared to M. bovis 12-14.  33	
 34	
The advent of systems for mutagenesis of mycobacteria allied with (largely) murine 35	
screens for phenotype has provided enormous insight into the virulence genes and pathogenic 36	
strategies of mycobacteria. Yet the basis for host preference across the MTBC is largely 37	
unknown. Members of the MTBC share >99% nucleotide identity across their genomes, with 38	
for example ~2,400 SNPs between M. bovis AF2122/97 and M. tuberculosis H37Rv 15-17. 39	
Regions of difference (RD), deleted loci absent from one MTBC member relative to another, 40	
serve as unique markers to differentiate species with some having had functional roles 41	
ascribed. The RD1 locus of M. tuberculosis encodes a type VII secretion system whose role in 42	
virulence of M. tuberculosis has been convincingly explored using a range of in vitro and 43	
model systems 18. However, RD1-like deletions from M. microti and the ‘dassie’ bacillus 44	
indicate that discrete evolutionary scenarios have moulded the virulence strategies and 45	
genomes of the MTBC bacilli 19,20. Similarly, functional impacts of single nucleotide 46	
polymorphisms (SNPs) between the various MTBC and their potential role in host-pathogen 47	
interaction have been described 21. Much work remains in describing the precise host and 48	
pathogen molecular factors involved in host preference 22.  49	
 50	
An essential step to defining host tropic factors is defining tractable experimental 51	
models; given the range of wild and domesticated mammals that are susceptible to infection 52	
by MTBC members, this is no small task. Nevertheless, with the aim of exploring MTBC host 53	
preference, we have previously explored the comparative virulence of M. tuberculosis and 54	
M. bovis in a bovine experimental infection model, and showed that M. tuberculosis H37Rv 55	
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was attenuated compared to M. bovis AF2122/97 13. However, while M. tuberculosis H37Rv 56	
is the reference strain of the MTBC, its isolation was first reported 1935 23 and it has been 57	
maintained in multiple laboratories globally, with separate extant ‘versions’ of 58	
M. tuberculosis H37Rv 24. The possibility remained that other M. tuberculosis clinical isolates 59	
would show a different phenotype in a bovine infection. Indeed, there have been increasing 60	
numbers of reports of the isolation of M. tuberculosis from cattle 25-27, including our own 61	
work where we previously isolated M. tuberculosis strains from lesions identified in cattle at 62	
slaughter in Ethiopian cattle 28,29. This would suggest that either there exist strains of 63	
M. tuberculosis with virulence characteristics that allow them to infect and cause disease in 64	
cattle, or that the cattle from which these M. tuberculosis strains were isolated had greater 65	
susceptibility to infection due to being immune comprised, co-infections, age, malnutrition, or 66	
other predisposing factors such as being in an environment of continuous exposure to 67	
M. tuberculosis. 68	
 69	
We therefore set out to evaluate the attenuated virulence of M. tuberculosis in the 70	
bovine host using a recent M. tuberculosis bovine isolate as the comparator. We chose to use 71	
an Ethiopian M. tuberculosis strain that had been isolated from a Zebu bull, M. tuberculosis 72	
BTB1558, to perform this new experimental infection in cattle, and to compare the virulence 73	
of this latter isolate to the M. tuberculosis H37Rv and M. bovis AF2122/97 strains.  74	
  75	
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Material and Methods 76	
 77	
Ethical permission 78	
Ethical permission was obtained from the APHA Animal Use Ethics Committee (UK 79	
Home Office PCD number 70/6905), AHRI/ALERT Ethics Review Committee (Ethiopia) 80	
and the French Research and Education Ministry, via the Val de Loire Ethical Committee 81	
(CEEAVDL, #19) for INRA (France).  82	
 83	
Mycobacterial strains and culturing protocols  84	
Three strains were used for this bovine challenge experiment: M. bovis AF2122/97 is 85	
a field strain isolated from a cow in Great Britain in 1997 16. M. tuberculosis H37Rv was from 86	
the APHA culture stocks. The virulence of both the M. bovis AF2122/97 and M. tuberculosis 87	
H37Rv stocks has been confirmed via inoculation of guinea pigs 13, with both seed stocks 88	
clearly virulent in this model. M. tuberculosis BTB1558 was isolated in 2008 from the cranial 89	
mediastinal lymph node of a Zebu bull (Bos indicus) at Ghimbi abattoir, Ethiopia. The lesion 90	
from which the strain was isolated was classed as localised, and was not caseous or calcified; 91	
no nasal secretions were present at the ante-mortem investigation. An M. tuberculosis strain 92	
of the same spoligotype as BTB1558 (SIT 764) was isolated from a human pulmonary TB 93	
patient in Ethiopia 30; both the cattle and the human isolate have been confirmed as members 94	
of the Euro-American lineage, also known as Lineage 4 31,32.  95	
 96	
M. bovis AF2122/97 and M. tuberculosis BTB1558 had been passaged a maximum of 97	
five times prior to the challenge experiment. Seed stocks had been cultured to mid-log phase 98	
in Middlebrook 7H9 media (Difco, UK) supplemented with 10% (v/v) Middlebrook acid-99	
albumin-dextrose-catalase enrichment (Difco), 4.16 g/l sodium pyruvate (Sigma-Aldrich, UK) 100	
and 0.05% (v/v) Tween 80 (Sigma-Aldrich) and stocks stored frozen at -80oC. The colony 101	
forming units (CFU)/ml of bacterial stocks, infection inoculum, and homogenised tissue was 102	
determined by bacterial enumeration of a serial dilution cultured on modified Middlebrook 103	
7H11 agar 33. Inoculated plates were incubated at 37oC for four weeks (six weeks for tissue 104	
samples) prior to enumeration of individual colonies on the agar plates. All seed stocks were 105	
confirmed with a viability of approximately 2 x 107 CFU/ml prior to further use.  106	
 107	
Preparation of M. bovis and M. tuberculosis infection inoculum 108	
Frozen seed stocks were thawed and diluted in 7H9 medium to a final concentration 109	
of approximately 5 x 103 CFU/ml. For each animal, 2ml of this infection inoculum were 110	
drawn into a 5ml Luer-lock syringe. An aliquot of the M. bovis AF2122/97, M. tuberculosis 111	
H37Rv, and M. tuberculosis BTB1558 inocula was retained to determine, retrospectively, the 112	
.CC-BY-NC-ND 4.0 International licensenot peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/202663doi: bioRxiv preprint first posted online Oct. 13, 2017; 
	 6	
concentration of bacilli used in each inoculum. Heat-inactivated samples of each strain were 113	
used to identify the strains by large sequence polymorphism 29,34 and spoligotyping 35. 114	 	115	
Cattle infection  116	
Twelve female Limousin x Simmenthal cattle of approximately six months of age 117	
raised from birth within INRA’s animal facility were divided into three groups of four. An 118	
infective dose of 1x104 CFU was targeted for each strain; inocula were delivered 119	
endobronchially in 2 ml of 7H9 medium as described previously 36. In brief, animals were 120	
sedated with xylazine (Rompun® 2%, Bayer, France) according to the manufacturer’s 121	
instructions (0.2 mL/100 kg, IV route) prior to the insertion of an endoscope through the nasal 122	
cavity into the trachea for delivery of the inoculum through a 1.8 mm internal diameter 123	
cannula (Veterinary Endoscopy Services, U.K.) above the bronchial opening to the cardiac 124	
lobe and the main bifurcation between left and right lobes. Two ml of PBS were used to rinse 125	
any remains of the inoculum into the trachea and then cannula and endoscope were 126	
withdrawn. The canal through which the cannula was inserted into the endoscope was rinsed 127	
with 20 ml of PBS and the outside of the endoscope was wiped with sterilizing wipes 128	
(Medichem International, U.K.) prior to infection of the next animal. Retrospective counting 129	
of the inocula revealed infection with 1.66x104 CFU M. tuberculosis H37Rv; 2.2x104 CFU 130	
M. tuberculosis BTB1558; and 1.12x104 CFU M. bovis AF2122/97.  131	
 132	
Monitoring of infection by the IFN-γ release Assay (IGRA) 133	
Blood was collected from animals one day prior to the infectious challenge (-1) and 134	
every two weeks after infection until the animals were culled. Heparinized whole blood 135	
(250µl) was incubated with a selection of mycobacterial antigens: PPD-Avium (PPD-A) or 136	
PPD-Bovine (PPD-B) (Prionics) respectively at 25 IU and 30 IU final; or peptide pools 137	
covering ESAT6/CFP10, Rv3873 or Rv3879c added in a volume of 25µl to a final 138	
concentration of 10µg/ml. Pokeweed mitogen was used as the positive control at 10µg/ml, 139	
and a media-only negative control also included. After 24h in 5% (v/v) CO2 atmosphere at 140	
37°C stimulated bloods were centrifuged (400xg for 5 min); 120µl of supernatant was 141	
removed and stored at -80°C for subsequent IFN-γ quantification using the Bovigam kit 142	
(Prionics) in accordance with the manufacturer’s instructions. 143	
For RNA extractions, 4 ml of heparinized whole blood was incubated with PBS or 144	
PPD-B in the same condition as described above. After 24 hr 3ml of stimulated blood were 145	
transferred to TempusTM Blood RNA tubes (Life Technologies) and stored at -80°C. The 146	
remaining 1ml was centrifuged and the supernatant stored at -80°C for cytokine analyses. 147	
 148	
Multiplex ELISA analyses 149	
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 PPD-B stimulated whole blood supernatants were assayed for cytokine levels using a 150	
custom-designed bovine Meso Scale Discovery® (MSD) multiplex protein analysis platform 151	
(Meso Scale Discovery®, Gaithersburg, MD, USA). The bovine cytokines analysed were: IL-152	
1β, IL-6, IL-10, IL-12, and TNF-α. Multiplex 96 well plates (supplied with target capture 153	
antibodies spotted onto separate carbon electrodes in each well) were blocked with MSD® 154	
assay buffer for 30 min at room temperature before the addition of 25µl samples or MSD® 155	
standards (prepared according to manufacturer’s instructions). Following 2h sample 156	
incubation at room temperature, plates were washed and incubated for a further 2h with a 157	
combined cocktail of biotinylated detection antibodies for each cytokine and MSD® SULFO-158	
TAG™-labelled Streptavidin (according to the manufacturers’ instructions). After a final 159	
wash, plates were coated with MSD® Buffer-T and luminescence (OD455nm) was measured on 160	
a SECTOR® Imager 6000 instrument (MSD). IL-6, IL-10 and IL-12 responses are reported as 161	
U/ml while IL-1β and TNF-α responses are reported in ng/ml as interpolated from the 162	
standard curves for each cytokine included on each plate.  163	
 164	
Gross pathology and histopathology 165	
Ten weeks after infection animals inoculated with M. tuberculosis were killed and 166	
subjected to post-mortem analysis as indicated elsewhere 37; animals inoculated with M. bovis 167	
were sacrificed six weeks after infection for post-mortem analysis as above. The presence of 168	
gross pathological TB-like lesions was scored as previously described (37). For histology, a 169	
cross-sectional slice of the lymph node was collected into a 100 ml pot containing buffered 170	
formalin. Collected tissue samples were shipped overnight from INRA to APHA Weybridge 171	
for subsequent processing.  172	
Tissues evaluated for gross pathology included the following lymph nodes: left and 173	
right parotid, lateral retropharyngeal, medial retropharyngeal, submandibular, caudal, cranial 174	
mediastinal and cranial tracheobronchial and pulmonary lymph nodes; lung tissue samples 175	
were also taken. Tissue samples were preserved in 10% phosphate buffered formalin for 7 176	
days before being embedded in paraffin wax. Four-micron sections were cut and stained with 177	
hematoxylin and eosin (H&E); Ziehl-Neelsen staining was carried out for the detection of 178	
acid-fast bacilli (AFB). For histopathology, sections of thoracic (caudal mediastinal, cranial 179	
mediastinal, cranial tracheobronchial, left and right bronchial) and extrathoracic (left and right 180	
parotid, left and right medial retropharyngeal, left and right lateral retropharyngeal, left and 181	
right mandibular) lymph nodes, left and right tonsils and lung were stained with for 182	
examination by light microscopy to assess the number, developmental stage and distribution 183	
of each granuloma (I-IV) as well as assessing the quantity and location of AFB as previously 184	
described 38,39. 185	
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 186	
Evaluation of tissue bacterial load 187	
For bacteriology, up to 20 g of tissue was collected into 25 ml sterile containers and 188	
frozen at -80oC on the day of collection. Frozen tissues were shipped at +4oC to APHA 189	
Weybridge and immediately upon arrival were homogenised using a Seward Stomacher 190	
Paddle Blender with bacterial enumeration undertaken as previously described 37.    Macerates 191	
were plated on modified 7H11 agar plates containing 10% (vol/vol) Middlebrook oleic acid-192	
albumin-dextrose-catalase enrichment 33. Plates were seeded with 500µl, 50µl and 5µl of 193	
macerate; 450µl and 500µl of PBS was added to the plates containing 50µl and 5µl 194	
respectively to help distribute the macerate on the whole plate. Using this method the limit of 195	
detection was 2 CFU/ml. 196	
 197	
RNA extraction and library preparation 198	
Thirty-two strand-specific RNA-Seq libraries were prepared from whole blood from 199	
M. bovis AF2122/7 and M. tuberculosis H37Rv infected animals (n=4) at day 14 and day 42 200	
that were either stimulated or not with PPD-B. Total RNA including miRNA was extracted 201	
from the Tempus™ Blood RNA Tubes using the Preserved Blood RNA Purification Kit I 202	
(Norgen Biotek Corp, Canada) according to the manufacturer’s instructions. Twelve random 203	
samples were chosen to assess RNA integrity using the RNA 6000 Nano Kit (Agilent) in 204	
conjunction with the Agilent 2100 Bioanalyzer. RNA Integrity Numbers (RINs) ranged from 205	
8 to 9.1 (8.6 average). RNA was quantified using the NanoDrop™ ND-1000 206	
Spectrophotometer (Thermo Fisher Scientific) and 200ng of total RNA was subjected to two 207	
rounds of Poly(A) mRNA purification using the Dynabeads® mRNA DIRECT™ Micro Kit 208	
(Invitrogen™) according to the manufacturer’s recommendations. The samples were prepared 209	
for sequencing using the ScriptSeq™ v2 RNA-Seq Library Preparation Kit, Index PCR 210	
Primers and the FailSafe™ PCR enzyme system according to manufacturer’s specifications 211	
(Illumina® Inc., Madison, WI, USA). The Agencourt® AMPure® XP system (Beckman 212	
Coulter Genomics, Danvers, MA, USA) was utilised to purify the resulting RNA-Seq 213	
libraries. Libraries were quantified using the Quant-iT dsDNA Assay Kit and subsequently 214	
pooled in equimolar concentrations (Thermo Fisher Scientific). The 32 sequencing libraries 215	
were pooled and sequenced over three lanes of an Illumina HiSeq 2500 Rapid Run flow cell 216	
(v1) in paired end (2 x 100 bp) format by Michigan State University Research Technology 217	
Support Facility, Michigan, USA. Base-calling and demultiplexing was performed with 218	
Illumina Real Time Analysis [v1.17.21.3] and Illumina Bcl2Fasta [v1.8.4] respectively. The 219	
RNA-Seq data has been deposited in the European Nucleotide Archive, accession number 220	
PRJEB22247.  221	
 222	
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RNA-Seq pipeline 223	
The pipelines used for the analysis of the RNA-Seq data are available on GitHub 224	
(https://github.com/kerrimalone). Computational analyses were performed on a 32-node 225	
Compute Server with Linux Ubuntu [version 12.04.2]. Briefly, pooled libraries were 226	
deconvoluted, adapter sequence contamination and paired-end reads of poor quality were 227	
removed using cutadapt [v1.13] (Phred > 28) 40 and the filterbytile.sh script from the BBMap 228	
package 41. At each step, read quality was assessed with FastQC [v0.11.5] 42. Paired-end reads 229	
were aligned to the Bos taurus reference genome (B. taurus UMD 3.1.1) with the STAR 230	
software 43. Read counts for each gene were calculated using featureCounts, set to 231	
unambiguously assign uniquely aligned paired-end reads in a stranded manner to gene exon 232	
annotation (B. taurus UMD 3.1.1 GCF_000003055.6) 44. Differential gene expression 233	
analysis was performed using the edgeR Bioconductor package that was customised to filter 234	
out all bovine ribosomal RNA (rRNA) genes, genes displaying expression levels below one 235	
count per million (CPM) in at least four individual libraries and identify differentially 236	
expressed (DE) genes correcting for multiple testing using the Benjamini-Hochberg method 237	
with a log2 fold change (log2FC) greater than 1/less than -1 and a False-Discovery Rate (FDR) 238	
threshold of significance ≤ 0.05 45. DE gene expression was evaluated between M. bovis and 239	
M. tuberculosis infected animals for unstimulated blood samples (unpaired statistics) for each 240	
time point in addition to between unstimulated and PPD-B-stimulated blood samples for the 241	
M. bovis and M. tuberculosis infected animals independently at each time point (paired 242	
statistics). Cellular functions and pathways over-represented in DE gene lists were assessed 243	
using the SIGORA R package while graphical representation of data results was achieved 244	
using the R packages ggplot2, VennDiagram and related supporting packages 46-48. 245	
 246	
miRNA RT-qPCR  247	
MicroRNA miR-155 was selected for analysis based on its suggested role in immune 248	
response to M. bovis infection 49. As the human and bovine sequences are identical, hsa-miR-249	
155-5p primers were purchased from Exiqon miRCURY UniRT miRNA primers (catalogue 250	
number 204308).  251	
 252	
 253	
  254	
.CC-BY-NC-ND 4.0 International licensenot peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/202663doi: bioRxiv preprint first posted online Oct. 13, 2017; 
	 10	
RESULTS  255	
 256	
Immune response in infected cattle 257	
Three groups of four cattle each were infected endobronchially with 1.66x104 CFU 258	
M. tuberculosis H37Rv, 2.2x104 CFU M. tuberculosis BTB1558, or 1.12x104 CFU M. bovis 259	
AF21222/97, respectively. Because of the need to restrict the total time the experiment would 260	
run in the containment facility, animals infected with M. tuberculosis strains H37Rv or 261	
BTB1558 were maintained for 10 weeks, while M. bovis AF2122/97-infected animals were 262	
maintained for 6 weeks, after which all animals underwent post-mortem examination. Antigen 263	
specific IFN-γ responses were detected against both PPD-B (data not shown) and a cocktail of 264	
ESAT-6/CFP-10 peptides (Figure 1) two to three weeks after infection, with no significant 265	
difference in responses between groups over the course of the infections. 266	
In previous work 13 we had seen that while stimulation of whole blood with the 267	
antigen Rv3879c triggered IFN-γ production in M. bovis-infected cattle, M. tuberculosis 268	
H37Rv-infected cattle showed no responses. In this current work Rv3879c stimulation of 269	
whole blood provided less definitive outcomes, as while Rv3879c triggered minimal IFN-γ 270	
responses in blood from M. tuberculosis H37Rv or BTB1558 infected animals, the baseline 271	
responses to Rv3879c stimulation in M. bovis AF2122/97 infected cattle were high prior to 272	
infection, and showed no increase in response over the course of infection (data not shown). 273	
Supernatants from PPD-B stimulated samples were also checked for IL-1β, IL-6, IL-274	
10, IL-12, and TNF-α production over the course of infection using the MSD multiplex 275	
platform (Figure 2). Over the first 6 weeks after infection, all animals showed similar 276	
responses to all strains, although M. tuberculosis BTB1558 generated higher IL-1β responses 277	
at day 28 compared to responses induced by M. tuberculosis H37Rv or M. bovis AF2122/97. 278	
M. tuberculosis BTB1558 induced higher production of IL-10, IL-12, and TNF-α than 279	
M. tuberculosis H37Rv at the later time points (days 56 and 70) due to responses waning in 280	
the M. tuberculosis H37Rv group from day 42 onwards. Less than 1U/mL of IL-6 were 281	
detected in both infection groups (data not shown).  282	
 283	
Gross pathology 284	
As described above, animals infected with M. bovis AF2122/97 were culled 6 weeks 285	
post-infection, while M. tuberculosis groups were culled after 10 weeks. Lungs and lymph 286	
nodes (thoracic and extrathoracic) were examined for gross lesions. Typical gross lesions 287	
were isolated granulomas or coalescing clusters of granulomas of variable size ranging from 5 288	
to 10 mm in diameter. Gross pathology scores are summarised in Figure 3(A-D). Statistically 289	
significant differences were observed in lung gross lesions of animals infected with M. bovis 290	
compared to animals infected with M. tuberculosis H37Rv or M. tuberculosis BTB1558; no 291	
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significant differences were observed comparing the lung lesions of the two sets of 292	
M. tuberculosis infected animals. Lung gross lesions were only observed in animals infected 293	
with M. bovis AF2122/97 with scores ranging from 5 to 10 and scores of 0 (no visible lesions) 294	
in animals infected with M. tuberculosis H37Rv or BTB1558. Thoracic lymph nodes (cranial 295	
mediastinal, caudal mediastinal, right bronchial, left bronchial and cranial tracheobronchial) 296	
showed a scores of between 4 and 14 in animals infected with M. bovis AF2122/97; animals 297	
infected with M. tuberculosis H37Rv had a score of 1; animals infected with M. tuberculosis 298	
BTB1558 had scores ranging of between 0 and 2; statistically significant differences were 299	
observed only between animals infected with M. bovis AF2122/97 and those infected with 300	
M. tuberculosis BTB1558. Extra-thoracic lymph nodes from the head and neck region (right 301	
and left lateral retropharyngeal, right and left medial retropharyngeal, right and left parotid 302	
and right and left submandibular) showed scores of between 0 and 7 in animals infected with 303	
M. bovis AF2122/97; scores of between 0 and 2 in animals infected with M. tuberculosis 304	
BTB1558; animals infected with M. tuberculosis H37Rv did not show any gross visible 305	
lesions in extra-thoracic lymph nodes. No statistically significant differences were observed 306	
between the three groups of infected animals in the lesions observed in these nodes. No 307	
lesions were found in the tonsils in any group. All animals showed TB-like gross lesions in at 308	
least one organ. 309	
 310	
Culture of M. bovis and M. tuberculosis from processed samples. 311	
The presence of bacteria in the harvested tissue samples was investigated by semi-312	
quantitative culture (Table 1). It was possible to culture the respective infecting strain from at 313	
least one organ from all experimental animals. However, the number of CFU/ml was usually 314	
low for animals infected with either of the two M. tuberculosis strains, with zero bacterial 315	
counts recorded in the lung or lung lymph nodes for all eight animals infected with either 316	
strain of M. tuberculosis. Respiratory lymph nodes were mostly affected, with all 12 animals 317	
having bacterial counts in this organ system (Table 1).   318	
 319	
Histopathology 320	
In H&E stained sections, four stages of granulomas were identified as previously 321	
described 39,50. Briefly, Stage I (initial) granulomas comprised clusters of epithelioid 322	
macrophages, low numbers of neutrophils and occasional Langhans’ multinucleated giant 323	
cells (MNGCs). Stage II (solid) granulomas were more regular in shape and surrounded by a 324	
thin and incomplete capsule. The cellular composition was primarily epithelioid 325	
macrophages, with Langhans’ MNGCs present and some infiltration of lymphocytes and 326	
neutrophils. Necrosis was minimal or not present. Stage III (necrotic) granulomas were all 327	
fully encapsulated with central areas of necrosis. The necrotic centres were surrounded by 328	
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epithelioid macrophages and Langhans’ MNGCs, and a peripheral zone of macrophages, 329	
clustered lymphocytes and isolated neutrophils extended to the fibrotic capsule. Stage IV 330	
(mineralised) granulomas were completely surrounded by a thick fibrous capsule and 331	
displayed central areas of caseous necrosis with extensive mineralization. The central necrosis 332	
was surrounded by epithelioid macrophages and Langhans’ MNGCs cells with a peripheral 333	
zone of macrophages and dense clusters of lymphocytes just inside the fibrous capsule. 334	
Granulomas were frequently multicentric, with several granulomas coalescing. 335	
The number of granulomas of each stage in each tissue was variable (Table 2). Most 336	
of the histopathological lesions were observed in the thoracic lymph nodes with only two 337	
animals from BTB1558 and two others from the M. bovis AF2122/97 group showing 338	
granulomas in extrathoracic lymph nodes. The number of granulomas observed in tissues 339	
from animals infected with M. bovis AF2122/97 was significantly higher than the small 340	
number of granulomas observed in animals infected with either strain of M. tuberculosis. 341	
Moreover, the majority of granulomas observed in both H37Rv and BTB1558 infected 342	
animals were classed as stage I, with a few stage II granulomas, while M. bovis AF2122/97 343	
infected animals showed granulomas of all development stages (I-IV) (Table 2). AFBs were 344	
identified in at least one ZN stained tissue section from every animal (data not shown) 345	
 346	
Transcriptome analysis of M. bovis AF2122/97 and M. tuberculosis H37Rv infected animals  347	
As the peripheral immune responses were broadly similar across all groups, yet 348	
pathological examination revealed significant differences, we used transcriptomic analysis of 349	
stimulated and non-stimulated whole blood samples as an unbiased tool to identifying global 350	
peripheral blood markers that would correlate with the pathological outcomes. We chose to 351	
analyse just the M. bovis AF2122/97 and M. tuberculosis H37Rv groups as they presented the 352	
extremes in terms of immune responses and pathological presentations. Blood samples 353	
cultured with medium alone (negative control) or with PPD-B from M. bovis AF2122/97 354	
(n=4) and M. tuberculosis H37Rv (n=4) infection groups at days 14 and 42 were selected for 355	
analysis. Strand-specific RNA-Seq libraries (n =32) were prepared from these blood samples 356	
and after sequencing on an Illumina HiSeq 2500, quality-control and filtering of sequencing 357	
reads yielded a mean of 14,981,780 paired-reads per individual library (2 x 100 nucleotides); 358	
these data satisfy previously defined criteria for RNA-Seq experiments with respect to 359	
sequencing depth 51-53. Alignment of filtered paired-end reads to the B. taurus reference 360	
genome UMD3.1.1 yielded a mean of ~13.5 million read pairs (~90.5%) mapping to unique 361	
locations per library. Gene count summarisation resulted in an average of 59% of read pairs 362	
being assigned to B. taurus reference genome annotations based on strict sense strand and 363	
counting specifications. Gene filtering resulted in 17,663 sense genes (57.5% of all B. taurus 364	
reference genes in the RefSeq annotations) that were suitable for differential expression 365	
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analysis. Multidimensional scaling analysis amongst the 32 sequencing libraries using the 366	
filtered and normalised gene counts (n = 17,663 genes) revealed that PPD-B stimulation was 367	
the largest discriminator that placed the samples into two distinct groups (Figure S1).  368	
 369	
Differential gene expression in unstimulated whole blood from M. bovis AF2122/97 and 370	
M. tuberculosis H37Rv infected animals 371	
Pairwise analysis of the transcriptome from unstimulated bovine whole blood 372	
samples at day 42 versus day 14 revealed increases in the number of differentially expressed 373	
(DE) genes at day 42 post infection with either M. bovis AF2122/97 or M. tuberculosis 374	
H37Rv (Figure 5A), with a greater number of genes found differentially expressed in 375	
M. tuberculosis H37Rv infected animals at day 42, respectively (344 vs. 70 genes).  376	
Direct comparison of unstimulated whole blood samples between M. bovis 377	
AF2122/97 and M. tuberculosis H37Rv infected animals at day 14 and again at day 42 378	
revealed 523 and 76 DE gene respectively, with 27 of these identified as DE at both time-379	
points (Figure 5A, green) between the two infection models. Amongst the top 10 DE genes 380	
upregulated in M. bovis AF2122/97 infected animals (or conversely, downregulated in 381	
M. tuberculosis H37Rv animals) included those encoding: the macrophage restricted cell 382	
surface receptor SIGLEC1 that is known to be involved in pathogen uptake, antigen 383	
presentation and lymphocyte proliferation 54; the CD4-coreceptor and fractalkine receptor 384	
CX3CR1, which has been linked to tuberculosis susceptibility and the impairment of 385	
macrophage and dendritic cell migration  55,56; and Interferon-Regulated Resistance GTP-386	
Binding Protein (MX1) at day 14 (Figure 5B). At day 42 the expression of the following genes 387	
was at relatively higher level in M. bovis AF2122/97 infected animals than in M. tuberculosis 388	
H37Rv infected animals (Figure 5B): CXCL9, a previously described potential TB biomarker 389	
50,57; mediator of mycobacterial-induced cytokine production in macrophages CD180 58; and 390	
the chemokine CXCL11.  391	
T-cell chemotactic factor CCL17 had the highest log-fold change in M. tuberculosis 392	
H37Rv infected samples in comparison to M. bovis AF2122/97 infections at day 14. Genes 393	
also expressed to a higher level in M. tuberculosis infected animals at day 14 were: the 394	
defensin DEFB10; platelet aggregation inducing factor PDPN, which is expressed on 395	
macrophages and epithelioid cells within the tuberculous granuloma 59; macrophage lipid 396	
export complex member ABCG1; and IL6 (in contrast with the ELISA data from the same 397	
time point, Figure 2). At day 42 post infection the fractalkine receptor CX3CR1, a marker of 398	
Th1 stage differentiation during tuberculosis 60, and the V-ATPase subunit gene ATP6V0D2 399	
were higher in M. tuberculosis H37Rv infected samples (Figure 5B).  400	
Pathway enrichment analysis revealed pathways such as Extracellular matrix 401	
organization (R-HSA-1474244), Collagen degradation (R-HSA-1442490), Interferon 402	
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alpha/beta signaling (R-HSA-909733) and B cell receptor second messenger signaling (R-403	
HSA-983695) being significantly associated with the 523 DE genes between M. tuberculosis 404	
and M. bovis AF2122/97 infected animals at day 14 (Bonferroni < 0.005) (Figure 6C, 6D). 405	
Further investigation revealed higher expression of 25/44 genes belonging to the antigen 406	
activation of B cell receptor signaling pathway (R-HSA-983695) in M. bovis AF2122/97 407	
infected animals at day 14, such as membrane associated CD19, CD80, TREM2 and second 408	
messengers LYN, SYK, BTK, BLNK, PLCG2 along with B-cell receptor encoding genes 409	
CD79a and CD79b (Figure 6D). The enrichment of collagen degradation and extracellular 410	
matrix organization pathways in the 523 DE gene list highlighted genes of the matrix 411	
metallopeptidase (MMP) family such as MMP1, MMP3, MMP12 and MMP14 (Figure 6C). 412	
MMP proteins have been linked to leukocyte migration and the progression of granuloma 413	
formation during tuberculosis; MMP1 and MMP14 gene products are key for the destruction 414	
of collagen and alveolar destruction with an increased expression of MMP14 gene found in 415	
the sputum of tuberculosis patients 61,62. Gene expression of the matrix-associated cytokine 416	
SPP1 (i.e. Osteopontin/OPN) was upregulated in M. bovis infected animals at day 14. SPP1 417	
enhances IFN-γ and IL-12 production, and increased levels of SPP1 have been reported in the 418	
blood of TB patients versus controls 63. 419	
Pathway enrichment analysis with the 76 common DE genes at day 42-post infection 420	
revealed no significantly associated pathways. 421	
 422	
Differential gene expression in PPD-B-stimulated whole blood from M. bovis AF2122/97 and 423	
M. tuberculosis H37Rv infected animals 424	
 To assess antigen-stimulated alteration in the whole blood transcriptome, blood 425	
samples were stimulated with PPD-B overnight and subsequently compared to unstimulated 426	
blood samples. PPD-B stimulation resulted in the differential expression of 2,622 and 1,586 427	
genes at day 14 and 1,446 and 2,107 at day 42 in M. bovis AF2122/97 and M. tuberculosis 428	
H37Rv infected animals respectively in comparison to control samples (Figure 6A).  429	
Firstly, a “core” response to PPD-B stimulation amounting to 658 genes was 430	
identified, representing genes that were consistently DE regardless of infectious agent or time 431	
post infection (Figure 6A). As expected, IFNY was strongly upregulated in stimulated blood 432	
samples at both time points in both M. bovis AF2122/97 and M. tuberculosis H37Rv infected 433	
animals (Figure 6B). Furthermore, 47/152 genes from the Interferon gamma signaling 434	
pathway (R-HSA-877300) were significantly differentially expressed (-0.75 < log2FC > 0.75) 435	
across the comparative groups and time points (Figure 6B). Pathway enrichment analysis of 436	
the 658 core response genes revealed significantly associated pathways such as those 437	
involved in TNF-signaling (R-HSA-5668541, R-HSA-5676594, R-HSA-5357786, R-HSA-438	
5669034), Chemokine receptors bind chemokines (R-HSA-380108), Antigen processing-439	
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Cross presentation (R-HSA-1236975) and Initial triggering of complement (R-HSA-173736) 440	
(Figure 6C). The change in expression of the genes within these pathways can be seen in 441	
Figure 6D; an overall downwards trend in genes encoding complement related factors was 442	
found (e.g. C1Q1, C1QA, CFD and CFP) along with strong upregulation of TNF-signaling 443	
related factors (e.g. TNF, NFKB2, TNFAIP3 and lymphotoxins alpha and beta LTA/LTB) 444	
upon PPD-B stimulation of whole blood samples (Figure 6D). 445	
 Second, there are 159 and 179 DE genes in either M. bovis AF2122/97 or 446	
M. tuberculosis H37Rv infected animals at both time points (Figure 6A). These 338 genes 447	
represent a divergence in response to PPD-B stimulation between the two infection groups 448	
and the top ranking genes amongst them are presented in Figure S2 (log2FC ratio). The 449	
increased expression of CCL17, DEFB10 and matrix metalloproteinase MMP12 with the 450	
decreased expression of bactericidal permeability increasing protein BPI, CD164 and IL5 451	
receptor IL5RA can differentiate M. bovis AF2122/97 infected animals from M. tuberculosis 452	
H37Rv infected animals at both day 14 and day 42 post infection upon PPD-B stimulation. 453	
Conversely, the increased expression of interferon inducible dyamin MX2 at day 14 and 454	
cytokine receptors IL22RA2 and XCR1 at day 42 post infection, and decreased expression of 455	
T-cell regulator TNFSF18 at day 14- and TLR5, defensin DEFB5 and V-ATPase subunit gene 456	
ATP6V0D2 at day 42- post infection, distinguished M. tuberculosis H37Rv infected from 457	
M. bovis AF2122/97 infected animals upon PPD-B stimulation.  458	
 459	
miR-155 analysis 460	
miR-155 has been identified as a potential biomarker of disease development and/or severity 461	
in cattle infected with M. bovis 49. To explore its utility, we analysed the expression of miR-462	
155 in whole blood from M. bovis AF2122/97 and M. tuberculosis H37Rv infected cattle in 463	
PPD-B stimulated vs. unstimulated whole blood over the infection time course using RT-464	
qPCR (Figure S3). The animals infected with M. tuberculosis H37Rv showed a steady 465	
increase in expression of miR-155 after PPD-B stimulation over the course of infection, while 466	
M. bovis infected animals showing a greater baseline expression prior to infection and hence a 467	
more modest increase over the time course. While a single miRNA may lack specificity as a 468	
biomarker, these results support the potential of miR-155 as a part of a biomarker panel to 469	
assess infection with tubercle bacilli.   470	
 471	
  472	
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Discussion 473	
 This work set out to explore whether a recent isolate of M. tuberculosis, recovered 474	
from a TB lesion identified in an Ethiopian bull, would trigger a similar immunological and 475	
pathological response to the M. tuberculosis H37Rv reference strain when used to 476	
experimentally infect cattle. This work sought to build on our previous study that had shown 477	
M. tuberculosis H37Rv to be attenuated in the bovine host but using a recent clinical isolate to 478	
address issues around possible laboratory-adaptation of the H37Rv strain that may have 479	
reduced its virulence in the bovine model. Furthermore we wished to see whether the 480	
application of transcriptomics would reveal potential biomarkers to differentiate between the 481	
initial stages of a progressive, active M. bovis infection and a more quiescent, latent infection 482	
with M. tuberculosis.  483	
 484	
Our results showed that both M. tuberculosis BTB1558 and M. tuberculosis H37Rv 485	
were considerably attenuated in the bovine host when compared to M. bovis AF2122/97. This 486	
is despite the fact that animals infected with either M. tuberculosis strain were left to progress 487	
for 10 weeks, while the M. bovis infected animals were culled 6 weeks after infection. 488	
M. bovis induced a greater level of pathology than either of the M. tuberculosis strains. 489	
Although M. tuberculosis BTB1558 appeared to induce a slightly greater level of pathology 490	
in head lymph nodes than M. tuberculosis H37Rv, this difference was not significant; no 491	
difference was detected in the level of pathology induced by either of the M. tuberculosis 492	
strains in respiratory lymph nodes or lungs. The apparent arrest of M. tuberculosis 493	
granulomas in stages I and II, compared to infection with M. bovis that produced lesions from 494	
stages I-IV is another striking difference in infection outcome. The bacteriological culture 495	
results showed that both strains of M. tuberculosis persisted in cattle, at least over the 10 496	
weeks of the infection time course.  497	
 498	
The kinetics and magnitude of peripheral blood responses across all three infection 499	
groups were broadly similar over the initial 6 week phase of infection. As analysis of antigen-500	
induced peripheral blood cytokine responses failed to reflect the distinct pathological 501	
presentations between the M. bovis AF2122/97 and M. tuberculosis groups, we applied RNA-502	
Seq transcriptomics of whole blood in an attempt to identify biomarkers that would better 503	
distinguish the groups, focusing on the M. bovis AF2122/97 and M. tuberculosis H37Rv 504	
groups. This analysis revealed discrete genes and pathways that distinguished the groups and 505	
were indicative of accelerated disease development in the M. bovis AF2122/97 infected 506	
animals, and included previously described biomarkers of disease progression or 507	
susceptibility such as MMPs, CX3CR1, CXCL9 and SSP1/OPN 50,57,60,62,63. These changes in 508	
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peripheral gene expression over the course on infection provide biomarker candidates of 509	
disease progression for validation in new studies.  510	
 511	
Classic experiments from the late 19th century by Smith, Koch and von Behring 512	
showed that bovine and human tubercle bacilli showed distinct virulence in animal models, 513	
and in particular that the human bacillus was attenuated when used to infect cattle. Our work 514	
has recapitulated these findings, using both the standard M. tuberculosis H37Rv strain as well 515	
as an M. tuberculosis isolate (BTB1558) recovered from a bovine lesion. The attenuation 516	
shown by the M. tuberculosis BTB1558 strain in this experimental model, compared to that 517	
seen in the field situation in Ethiopia, therefore appears likely due to increased susceptibility 518	
of the affected animal. It should be noted however that from a human and animal health 519	
perspective, it is possible that cattle infected with M. tuberculosis may still be transmissible 520	
and shed bacilli (e.g. through nasal secretions, aerosol from the lungs or through milk) albeit 521	
at low levels. Such scenarios are more probable in countries where the case rates of active 522	
human TB are high, interaction between humans and cattle are frequent, and consumption of 523	
raw milk common.  524	
 525	
While the outcome of infection with M. tuberculosis in humans is likely more a 526	
spectrum than a bipolar, active vs. latent, state 64,65, infection with M. tuberculosis in cattle 527	
could be indicative of a latent infection being established, as compared to an active disease 528	
status upon M. bovis infection. The bovine infection model may therefore offer a tractable 529	
experimental system in which to explore the reactivation of M. tuberculosis infection and to 530	
define prognostic biomarkers of the development of active disease. Furthermore, infection of 531	
cattle with M. tuberculosis to establish latent infection may provide a tractable outbred model 532	
in which to explore post-exposure vaccination strategies.  533	
 534	
In conclusion, our work has shown that M. tuberculosis isolates, whether the H37Rv 535	
type strain or a recent isolate, are attenuated for virulence in a bovine infection model as 536	
compared to M. bovis. This work provides further evidence of the distinct host preference of 537	
tubercle bacilli as a basis to explore the molecular basis of virulence in M. bovis as compared 538	
to M. tuberculosis, and also offers a model in which to explore the reactivation of latent TB 539	
infection.  540	
 541	
 542	
 543	
  544	
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Table 1: Bacteriology of investigated organs.  
Strain M. bovis AF2122/97 M. tuberculosis H37Rv M. tuberculosis BTB1558 
Animal ID 1217 1221 1222 1224 1201 1203 1213 1211 1202 1207 1209 1215 
Head LN ¶ 0/8 * 2/8 6/8 5/8 0/8 1/8 2/6 0/8 2/7 2/8 1/8 1/8 
Resp LN ¶ 5/5 5/5 4/5 5/5 1/5 2/5 2/5 3/5 3/5 1/5 4/4 2/5 
 Lung* 2/2 1/2 1/1 2/2 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 
 
¶LN = lymph nodes; see Materials and Methods for details of tissues examined.  
*Number of tissues sampled in each organ system per challenged animal that were confirmed as culture 
positive with the respective infecting strain; hence 0/8 in head lymph nodes means no positive cultures from 8 
samples taken.  
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Table 2: Granuloma presentations in infected cattle 
 
Strain Stage I¶ Stage II Stage III Stage IV 
M. tuberculosis H37Rv 31 2 0 0 
M. tuberculosis H37Rv 20 5 0 0 
M. bovis AF2122/97 74 117 51 81 
 
¶Sections were scored for granuloma stages: stage I (initial), stage II (solid), stage III (necrotic) and 
stage IV (mineralised). Granuloma development in both M. tuberculosis strains is significantly 
different from M. bovis AF2122/97, P<0.001 (X-sq for trend)  
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Figure 1: Infection of cattle with M. tuberculosis H37Rv, M. tuberculosis BTB1558 or M. bovis 
AF2122/97 induces similar peripheral immune responses. 
Blood was collected at regular intervals from cattle prior to and after experimental infection with 
M. tuberculosis H37Rv (n=4), M. tuberculosis BTB1558 (n=4), or M. bovis AF2122/97 (n=4). Whole 
blood was isolated and stimulated with a cocktail of peptides derived from ESAT-6 and CFP-10. The 
responses in the infected cattle are shown: M. tuberculosis H37Rv (squares); M. tuberculosis 
BTB1558 (triangles); M. bovis AF2122/97 (circles). M. bovis infected animals were maintained for 6 
weeks, M. tuberculosis groups for 10 weeks. Data for each time point is presented as the mean 
response + SEM.  
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Figure 2: Cytokine analysis of stimulated whole blood from M. tuberculosis H37Rv, 
M. tuberculosis BTB1558 or M. bovis AF2122/97 infected cattle  
PPD-B stimulated-whole blood supernatants were assayed for IL-1β, IL-10, IL-12 (D), and TNF-
α cytokine levels using a custom-designed bovine MSD. The response in the M. tuberculosis H37Rv 
infected cattle is shown as squares; M. tuberculosis BTB1558 is shown as triangles; and M. bovis 
AF2122/97 shown as circles; all groups contained 4 animals. IL-10 and IL-12 responses are reported 
as U/ml while IL-1β and TNF-α responses are reported in ng/ml as interpolated from the standard 
curves for each cytokine included on each plate. Data for each time point is presented as the mean 
response + SEM.  
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Figure 3: Pathology scores across M. tuberculosis H37Rv, M. tuberculosis BTB1558 or M. bovis 
AF2122/97 infected cattle 
Pathology scores in the thoracic (A), extra thoracic lymph nodes (LNs) (B), and lungs (C) of animals 
infected with M. tuberculosis H37Rv (squares); M. tuberculosis BTB1558 (triangles), or M. bovis 
AF2122/97 (circles). Total gross pathology score is shown in (D). Data for each time point is 
presented as the mean response + SEM. This difference was statistically significant in the lungs (ρ 
0.0052) and in the total pathology score (ρ 0.0105).  
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Figure 4: Transcriptome analysis of unstimulated whole blood after M. bovis AF2122/97 or 
M. tuberculosis H37Rv infection 
(A) The number of differentially expressed genes in unstimulated whole blood for M. bovis- (blue) 
and M. tuberculosis- (purple) infected animals at day 42 -v- day 14 post infection (-1 > log2FC < 1, 
FDR < 0.05). The green Venn diagram depicts the overlap of differentially expressed genes from the 
direct comparison of unstimulated whole blood samples from M. bovis and M. tuberculosis infected 
animals at day 14 and day 42 post infection (-1 > log2FC < 1, FDR < 0.05). (B) The top 10 
differentially expressed genes between M. bovis- (blue) and M. tuberculosis- (purple) infected 
animals at day 14- and day 42-post infection (FDR < 0.05). The graph depicts positive relative log2 
fold change values where a gene that shows increased expression in M. bovis infected animals is 
relative to its expression in M. tuberculosis infected animals and vice versa. (C) Pathway enrichment 
analysis results for the list of 523 differentially expressed genes between M. bovis and 
M. tuberculosis infected animals at day 14-post infection. The graph depicts the enrichment of each 
pathway in the differentially expressed gene list based on the SIGORA successes metric (circle size) 
and the number of genes annotated within the pathway (“#genes in pathway”) while the colour bar 
depicts the significance of the association (Bonferroni < 0.05). (D) The relative expression 
(transcripts per million, TPM, “log(TPM +1)”) and the relative change in expression (log2 fold 
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change (“Log2FC”)) of the genes belonging to the Antigen activation of B cell Receptor (R-HSA-
983695), Collagen degradation (R-HSA-1442490) and Extracellular matrix (“ECM”) organization 
(R-HSA-1474244) pathways enriched for the comparison of M. bovis and M. tuberculosis infected 
animals at day 14 post infection. Genes that pass multiple hypothesis testing are denoted with an 
asterisk (Benjamini-Hochberg, FDR < 0.05) (*). 
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Figure 5: Comparative transcriptome analysis of unstimulated vs. PPD-B stimulated whole 
blood from M. bovis AF2122/97 or M. tuberculosis H37Rv infected cattle 
(A) The overlap of differentially expressed genes from the comparison of unstimulated whole blood 
samples and PPD-B stimulated whole blood samples for M. bovis AF2122/97 infected animals at day 
14 and day 42 (blue) and M. tuberculosis H37Rv infected animals at day 14 and day 42 (purple) (-1 > 
log2FC < 1, FDR < 0.05). (B) The relative expression of Interferon stimulated genes (R-HSA-
877300) from the comparison of unstimulated whole blood samples and PPD-B stimulated whole 
blood samples for M. bovis AF2122/97 infected animals at day 14 and day 42 (blue) and 
M. tuberculosis H37Rv infected animals at day 14 and day 42 (purple). Genes that pass multiple 
hypothesis testing are denoted with an asterisk (Benjamini-Hochberg, FDR < 0.05) (*). (C) Pathway 
enrichment analysis results for 658 genes that are significantly differentially expressed (-1 > log2FC 
< 1, FDR < 0.05) in PPD-B stimulated whole blood samples from both M. bovis AF2122/97- and 
M. tuberculosis H37Rv- infected animals at both 14 and 42 days post infection in comparison to 
unstimulated whole blood samples. The graph depicts the association of each pathway with the 
differentially expressed gene list based on the SIGORA successes metric (circle size) and the number 
of genes annotated within the pathway (“#genes in pathway”) while the colour bar depicts the 
significance of the association (Bonferroni < 0.05). (D) The relative expression (transcripts per 
million, TPM, “log(TPM +1)”) and the relative change in expression (log2 fold change (“Log2FC”)) 
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of 658 genes that are significantly differentially expressed (-1 > log2FC < 1, FDR < 0.05) in PPD-B 
stimulated whole blood samples from both M. bovis AF2122/97- and M. tuberculosis H37Rv- 
infected animals at both 14 and 42 days post infection in comparison to unstimulated whole blood 
samples. The genes are associated with pathways related to TNF signalling (R-HSA-5668541, R-
HSA-5676594, R-HSA-5357786, R-HSA-5669034), Antigen processing-Cross presentation (R-HSA-
1236975) and Chemokines and complement activation (R-HSA-380108, R-HSA-173736). Genes that 
pass multiple hypothesis testing are denoted with an asterisk (Benjamini-Hochberg, FDR < 0.05) (*).  
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Figure S1: Genome-wide gene expression correlation  
Genome-wide gene expression correlation between the 32 study samples pertaining to whole blood 
samples (unstimulated (“-“) or PPDb-stimulated (“PPDB”)) from cattle infected with either M. bovis 
AF2122/97 (“M. bovis”) or M. tuberculosis H37Rv (“MTB”) 14 days or 42 days (“Time”) post 
infection. Samples are clustered using Euclidean distance and coloured bars on the left of the plot 
denote the variables time point (“Time”), infection status (“Infection”) and stimulation status 
(“Condition”) for each of the 32 samples. 
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Figure S2: Top DE genes in unstimulated vs. stimulated whole blood between M. bovis 
AF2122/97 and M. tuberculosis H37Rv infected animals 
The top 10 upregulated and top 10 downregulated differentially expressed genes in whole blood 
samples derived from M. bovis AF2122/97 versus M. tuberculosis H37Rv infected animals and 
stimulated with PPD-B at day 14 and day 42 post infection. The change in gene expression from the 
comparison of stimulated blood to unstimulated blood at each time point for either M. bovis 
AF2122/97 or M. tuberculosis H37Rv infected animals was used to calculate log2FC ratio (i.e. 
expression of gene X in M. bovis AF2122/97 infected animals at day 14-post infection divided by 
expression of gene X in M. tuberculosis H37Rv infected animals at day 14-post infection).
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Figure S3: miR-155 analysis across M. bovis AF2122/97 and M. tuberculosis H37Rv infected 
animals 
The level of miR-155 in PPD-B stimulated vs. unstimulated whole blood from M. bovis AF2122/97 
(circles) and M. tuberculosis H37Rv (squares) infected cattle was assessed over the infection time 
course using RT-qPCR with Exiqon miRCURY UniRT miRNA hsa-miR-155-5p primers.  
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